TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/3/24 16:04 | 1/1/24 | FBRX | Forte Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chen Hubert C | TX | O | See rema | M.d | 0 | 0.00 | 0 | 8 | 9 | 93 | D | ||||||||||||||
10/3/23 16:29 | 10/1/23 | FBRX | Forte Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chen Hubert C | TX | O | See rema | M.d | 0 | 0.00 | 0 | 8 | 9 | 89 | D | ||||||||||||||
7/5/23 16:08 | 7/1/23 | FBRX | Forte Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chen Hubert C | TX | O | See rema | M.d | 0 | 0.00 | 0 | 8 | 324 | 10 | D | ||||||||||||||
4/4/23 20:17 | 4/1/23 | FBRX | Forte Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chen Hubert C | TX | O | See rema | M.d | 0 | 0.00 | 0 | 8 | 5 | D | |||||||||||||||
5/20/21 18:54 | 5/20/21 | MTCR | Metacrine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chen Hubert C | CA | O | Chief Me | P | 12 | 3.60 | 0 | 3 | New | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |